Junshi Biosciences Announces Collaboration with Dr. Reddy鈥檚 to Develop and Commercialize Toripalimab in 21 Countries

SHANGHAI, China, May 7, 2023 (GLOBE NEWSWIRE) — Shanghai Junshi Biosciences Co., Ltd (鈥淛unshi Biosciences鈥? HKEX: 1877; SSE: 688180) announced a collaboration with Dr. Reddy鈥檚 Laboratories Limited (鈥淒r. Reddy鈥檚鈥? to develop and commercialize toripalimab, the anti-PD-1 monoclonal antibody in Latin America, India , South Africa, and at the election of Dr. Reddy鈥檚, also in Australia, New Zealand and other countries.